Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mads Jeppe Tarp-Johansen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|June 2, 2022
Fast tipping point sensitivity analyses in clinical trials with missing continuous outcomes under multiple imputationAnders Gorst-Rasmussen, Mads Jeppe Tarp-Johansen
JAMA|March 3, 2016
Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical TrialIldiko Lingvay, Federico Pérez Manghi, Pedro García-Hernández, et al.
Diabetes Care|September 19, 2019
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 TrialBernard Zinman, Vanita R Aroda, John B Buse, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|June 2, 2022
Fast tipping point sensitivity analyses in clinical trials with missing continuous outcomes under multiple imputationAnders Gorst-Rasmussen, Mads Jeppe Tarp-Johansen
JAMA|March 3, 2016
Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical TrialIldiko Lingvay, Federico Pérez Manghi, Pedro García-Hernández, et al.
Diabetes Care|September 19, 2019
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 TrialBernard Zinman, Vanita R Aroda, John B Buse, et al.
Pageof 1